Compare SRRK & URBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SRRK | URBN |
|---|---|---|
| Founded | 2012 | 1970 |
| Country | United States | United States |
| Employees | 289 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Clothing/Shoe/Accessory Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.8B | 6.6B |
| IPO Year | 2018 | 1995 |
| Metric | SRRK | URBN |
|---|---|---|
| Price | $56.97 | $68.93 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 12 |
| Target Price | $56.17 | ★ $86.91 |
| AVG Volume (30 Days) | ★ 1.5M | 1.1M |
| Earning Date | 05-07-2026 | 05-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 18.78 |
| EPS | N/A | ★ 1.30 |
| Revenue | N/A | ★ $6,165,376,000.00 |
| Revenue This Year | N/A | $10.67 |
| Revenue Next Year | $534.24 | $7.01 |
| P/E Ratio | ★ N/A | $53.28 |
| Revenue Growth | N/A | ★ 11.07 |
| 52 Week Low | $27.07 | $59.54 |
| 52 Week High | $58.12 | $84.35 |
| Indicator | SRRK | URBN |
|---|---|---|
| Relative Strength Index (RSI) | 67.12 | 42.85 |
| Support Level | $41.38 | $66.39 |
| Resistance Level | N/A | $73.74 |
| Average True Range (ATR) | 2.45 | 2.43 |
| MACD | 0.52 | -0.50 |
| Stochastic Oscillator | 85.32 | 31.63 |
Scholar Rock Holding Corp is a biopharmaceutical company focused on improving the lives of children and adults with Spinal Muscular Atrophy and other rare, severe, and debilitating neuromuscular diseases. Its pipeline candidates include apitegromab and a subcutaneous formulation of apitegromab. The clinical-stage pipeline also includes SRK-439, an investigational subcutaneously administered fully human anti-pro/latent myostatin antibody with high inhibitory potency and selectivity toward myostatin, being developed for the treatment of rare neuromuscular diseases. The company also maintains early-stage programs focused on therapies for rare, severe, and debilitating neuromuscular diseases.
Founded in 1970, Philadelphia-based Urban Outfitters is a multibrand apparel and home goods retailer that operates nearly 800 stores and e-commerce in the US, which accounts for about 87% of sales, as well as in other regions. Its retail nameplates are Urban Outfitters (22% of fiscal 2026 sales), Free People/Movement (26%), and Anthropologie (42%). Retail accounted for 86% of fiscal 2026 revenue, but Urban Outfitters also sells products through a wholesale operation, owns some restaurants, and operates a fast-growing clothing rental and resale business called Nuuly (9% of sales). Urban Outfitters primarily markets to young adults and offers products across apparel (66% of sales), home goods (16% of sales), accessories (13% of sales), and more.